The CHU Grenoble research hospital in France has started a clinical trial to evaluate the efficacy of the Remedee Labs endorphin stimulation therapy for peri-surgical pain. The aim of the trial is to test the diminution of morphine consumption for patients who have undergone an aortic valve replacement.
The Principal Investigator is Pr. Albaladejo of the hospital’s Anesthesia & Intensive Care service. The test is expected to run through the end of 2020.
The preparation of additional trials into arthritis and migraine is also underway.
